Collect. Czech. Chem. Commun. 2007, 72, 965-983
https://doi.org/10.1135/cccc20070965

Bifunctional Acyclic Nucleoside Phosphonates: 2. Symmetrical 2-{[Bis(phosphono)methoxy]methyl}ethyl Derivatives of Purines and Pyrimidines

Silvie Vrbková*, Martin Dračínský and Antonín Holý

Centre for New Antivirals and Antineoplastics, Gilead Sciences & IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic

References

1. Roy-Burman P.: Analogues of Nucleic Acids Components. Springer Verlag, Berlin 1970.
2. Harnden M. J. (Ed.): Approaches to Antiviral Agents. Macmillan Press, London 1985.
3. De Clercq E., Walker R. T. (Eds): Targets for the Design of Antiviral Agents. Plenum Press, New York 1980.
4. Elion G. B., Furman P. A., Fyfe J. A., DeMiranda P., Beauchamp L., Schaeffer H. J.: Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 5716. <https://doi.org/10.1073/pnas.74.12.5716>
5. Schaeffer H. J., Beauchamp L., DeMiranda P., Elion G. B., Bauer D. J., Collins P.: Nature 1978, 272, 583. <https://doi.org/10.1038/272583a0>
6. Ogilvie K. K., Cheriyan U. O., Radatus B. K., Smith K. O., Galloway K. S., Kennell W. L.: Can. J. Chem. 1982, 60, 3005. <https://doi.org/10.1139/v82-430>
7. Martin J. C., Dvořák C. A., Smee D. F., Matthews T. R., Verheyden J. P. H.: J. Med. Chem. 1983, 26, 759. <https://doi.org/10.1021/jm00359a023>
8. Holý A.: Chem. Listy 1987, 81, 461.
9. Holý A.: Collect. Czech. Chem. Commun. 1978, 43, 3103. <https://doi.org/10.1135/cccc19783103>
10. Holý A.: Antiviral Res. 2006, 71, 248. <https://doi.org/10.1016/j.antiviral.2006.06.002>
11. De Clercq E.: Clin. Microbiol. Rev. 2003, 16, 569. <https://doi.org/10.1128/CMR.16.4.569-596.2003>
12. De Clercq E., Holý A.: Nat. Rev. Drug Discovery 2005, 4, 928. <https://doi.org/10.1038/nrd1877>
13. Neyts J., Leyssen P., Verbeken E., De Clercq E.: Antimicrob. Agents Chemother. 2004, 48, 2267. <https://doi.org/10.1128/AAC.48.6.2267-2273.2004>
14. Tsai C. C., Follis K. E., Sabo A., Beck T. W., Grant R. F., Bischofberger N., Benveniste R. E., Black R.: Science 1995, 270, 1197. <https://doi.org/10.1126/science.270.5239.1197>
15. Hadziyannis S. J., Tassopoulos N. C., Heathcote E. J., Chang T. T., Kitis G., Rizzetto M., Marcellin P., Lim S. G., Goodman Z., Wulfsohn M. S., Xiong S., Fry J., Brosgart C. L.: New Engl. J. Med. 2003, 348, 800. <https://doi.org/10.1056/NEJMoa021812>
16. Holý A., Votruba I., Masojídková M., Andrei G., Snoeck R., Naesens L., De Clercq E., Balzarini J.: J. Med. Chem. 2002, 45, 1918. <https://doi.org/10.1021/jm011095y>
17. Balzarini J., Pannecouque C., De Clercq E., Aquaro S., Perno C. F., Egberink H., Holý A.: Antimicrob. Agents Chemother. 2002, 46, 2185. <https://doi.org/10.1128/AAC.46.7.2185-2193.2002>
18a. Hocková D., Holý A., Masojídková M., Andrei G., Snoeck R., De Clercq E., Balzarini J.: J. Med. Chem. 2003, 46, 5064. <https://doi.org/10.1021/jm030932o>
18b. Hocková D., Holý A., Masojídková M., Andrei G., Snoeck R., De Clercq E., Balzarini J.: Bioorg. Med. Chem. 2004, 12, 3197. <https://doi.org/10.1016/j.bmc.2004.04.002>
19. Cattaneo M., Lecchi A., Ohno M., Joshi B. V., Besada P., Tchilibon S., Lombardi R., Bischofberger N., Harden T. K., Jacobson K. A.: Biochem. Pharmacol. 2004, 68, 1995. <https://doi.org/10.1016/j.bcp.2004.06.026>
20. Vrbovská S., Holý A., Pohl R., Masojídková M.: Collect. Czech. Chem. Commun. 2006, 71, 543. <https://doi.org/10.1135/cccc20060543>
21. Bates H. A., Farina J., Tong M.: J. Org. Chem. 1986, 51, 2637. <https://doi.org/10.1021/jo00364a003>
22. Krapcho A. P., Weimaster J. F., Eldridge J. M., Jahngen E., Lovey A. J., Stephens W. P.: J. Org. Chem. 1978, 43, 138. <https://doi.org/10.1021/jo00395a032>
23. Krapcho A. P., Jahngen E., Lovey A. J.: Tetrahedron Lett. 1974, 15, 1091. <https://doi.org/10.1016/S0040-4039(01)82414-X>
24. Dekmezian A. H., Kaloustian M. K.: Synth. Commun. 1979, 9, 431. <https://doi.org/10.1080/00397917908064173>